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Abstract
Adenosine and ATP, via their speciﬁc P1 and P2 receptors, modulate a wide variety of cellular and tissue functions, playing a
neuroprotective or neurodegenerative role in brain damage conditions. Although, in general, adenosine inhibits excitability and ATP
functions as an excitatory transmitter in the central nervous system, recent data suggest the existence of a heterodimerization and a
functional interaction between P1 and P2 receptors in the brain. In particular, interactions of adenosine A1 and P2Y1 receptors may
play important roles in the purinergic signalling cascade. In the present work, we investigated the subcellular localization⁄co-
localization of the receptors and their functional cross-talk at the membrane level in Wistar rat hippocampus. This is a particularly
vulnerable brain area, which is sensitive to adenosine- and ATP-mediated control of glutamatergic transmission. The postembedding
immunogold electron microscopy technique showed that the two receptors are co-localized at the synaptic membranes and
surrounding astroglial membranes of glutamatergic synapses. To investigate the functional cross-talk between the two types of
purinergic receptors, we evaluated the reciprocal effects of their activation on their G protein coupling. P2Y1 receptor stimulation
impaired the potency of A1 receptor coupling to G protein, whereas the stimulation of A1 receptors increased the functional
responsiveness of P2Y1 receptors. The results demonstrated an A1–P2Y1 receptor co-localization at glutamatergic synapses and
surrounding astrocytes and a functional interaction between these receptors in hippocampus, suggesting ATP and adenosine can
interact in purine-mediated signalling. This may be particularly important during pathological conditions, when large amounts of these
mediators are released.
Introduction
ATP and adenosine, via their speciﬁc P2 and P1 purinergic receptors
(Fredholm et al., 1994), mediate a wide variety of physiological
processes including neuromodulation and neurotransmission. More-
over, the purinergic system has been implicated in many pathological
and neurodegenerative conditions, in which massive release of ATP
and, in turn, ADP and adenosine production, occur from damaged or
dying cells, i.e. following ischemia, necrosis or trauma (Rathbone
et al., 1999; Burnstock, 2004). Several reports have described a
dualistic neuroprotective-neuromodulatory role of ATP interacting
with the speciﬁc ionotropic receptors (P2XR) and G protein coupled
receptors (GPCRs; P2YR) (Fredholm et al., 1994). Among P2YR,
P2Y1 receptors (P2Y1R) appear to be of particular interest in patho-
physiological mechanisms with both detrimental and beneﬁcial effects
(Franke & Illes, 2006). On the other hand, through the activation of
the inhibitory A1 adenosine receptor (A1R) coupled to G proteins
(Dunwiddie & Masino, 2001), adenosine inhibits the release of
excitatory neurotransmitters and decreases neuronal excitability,
exerting a neuroprotective role (Wardas, 2002).
Recent data have provided evidence for the existence of an
association between A1R and P2Y1R. In a co-transfected cell line
model these receptors interact directly (Yoshioka & Nakata, 2004) to
generate a hetero-oligomer, which has novel pharmacological and
functional characteristics indicating a potential role in the purinergic-
signalling cascade. A1R and P2Y1R have been suggested to be
involved in the modulation of brain damage and contribute, alone or in
combination, to neuro-degenerative⁄-regenerative processes (Neary
et al., 2003; Franke & Illes, 2006; Von Kugelgen, 2006). Moreover,
co-localization of these receptors has been demonstrated by immuno-
ﬂuorescence and immunoprecipitation (Yoshioka et al., 2002).
However, no data are at present available on the precise localiza-
tion⁄co-localization of A1 and P2Y1 receptors at cellular and
subcellular levels, or on their reciprocal modulation⁄functional
interaction in the native brain.
Hippocampus is a brain area with a speciﬁc vulnerability to injuries,
in particular to ischemia (Harry & Lefebvre d’Hellencourt, 2003). In
the hippocampus, A1R and P2Y1R are particularly abundant (Gottlieb
& Matute, 1997; Ochiishi et al., 1999; Jimenez et al., 2000; Moran-
Jimenez & Matute, 2000; Zhu & Kimelberg, 2001) and involved in the
modulation of glutamate release (Rudolphi et al., 1992; Mendoza-
Fernandez et al., 2000; Masino et al., 2002; Koizumi et al., 2003;
Kawamura et al., 2004; Rodrigues et al., 2005; Jourdain et al., 2007),
hence contributing to neurotransmission and neuro-degenerative and -
regenerative processes.
In the present work, we investigated the localization⁄co-localization
of A1R and P2Y1R in rat hippocampus, focusing on glutamatergic
synapses and using electron microscopic (EM) quantiﬁcation
Correspondence: Dr Linda H. Bergersen, as above.
E-mail: l.h.bergersen@medisin.uio.no
Re-use of this article is permitted in accordance with the Creative Commons Deed,
Attribution 2.5, which does not permit commercial exploitation.
Received 13 February 2007, revised 30 May 2007, accepted 11 June 2007
European Journal of Neuroscience, Vol. 26, pp. 890–902, 2007 doi:10.1111/j.1460-9568.2007.05697.x
ª The Authors (2007). Journal Compilation ª Federation of European Neuroscience Societies and Blackwell Publishing Ltdof postembedding immunogold labelling; this technique allows the
precise localization of proteins to be identiﬁed at subcellular
resolution, on different parts of astrocytes and neurons.
As a ﬁrst step to investigate the functional A1R and P2Y1R cross-
talk, we studied the A1R activation following P2Y1R stimulation and




assay (Lorenzen et al., 1993, 1996) was used. The GTP binding
represents the initial step of any GPCR activation and of the intra-
cellular signalling cascade mediated by GPCRs (Lorenzen et al., 1996).
Materials and methods
Materials
The A1R antibody was obtained commercially from Alpha Diagnostic
International (San Antonio, TX, USA) and the P2Y1R antibody from
Alomone Laboratories (Jerusalem, Israel). The data sheets supplied by
the manufacturers showed monospeciﬁcity by immunoblotting of rat
brain. The A1R antibody was raised against a 14-amino-acid peptide
corresponding to amino acid residues 163–176 of the rat or human
receptor protein, i.e. the epitope is in the presumed extracellular
N-terminal domain. The P2Y1R antibody was raised against a
17-amino-acid peptide (C) RALIYKDLDNSPLRRKS, corresponding
to residues 242–258 of rat or human P2Y1R, i.e. the epitope location is
in the presumed third intracellular loop (i3) between the TM5 and
TM6 domains. Secondary antibody, goat anti-rabbit IgG-HRP conju-
gate, was from Calbiochem (EMD Biosciences, afﬁliate of Merck
kgaA, Darmstadt, Germany). Goat anti-rabbit immunoglobulins
coupled to 10-nm or 15-nm gold particles were obtained from Aurion
(Wageningen, The Netherlands). Secondary antibody, goat anti-rabbit
IgG-HRP conjugate, was from Calbiochem (EMD Biosciences,
afﬁliate of Merck kgaA, Darmstadt, Germany). Electrophoresis
reagents were purchased from Bio-Rad (Hercules, CA, USA); full
range rainbow molecular weight markers (range 10–250 kDa) were
obtained from Amersham Biosciences (Freiburg, Germany).
[
35S]GTPcS (speciﬁc activity 1000 Ci⁄mmol) was purchased from
Amersham Biosciences Europe GmbH (Freiburg, Germany); adeno-
sine deaminase (ADA) was from Roche Diagnostics GmbH
(Mannheim, Germany). N
6-cyclohexyl adenosine (CHA), 8-cyclo-
pentyl-1,3-dipropylxanthine (DPCPX), GDP, guanosine-5¢-(c-thio)tri-
phosphate (GTPcS), 2-methylthio-adenosine 5¢-diphosphate
(MeSADP), 2¢-deoxy-N
6-methyl adenosine 3¢,5¢-diphosphate
(MRS2179), and protease inhibitors were obtained from Sigma
Chemical Co (St Louis, MO, USA). The protein concentration of
the samples was established using the protein assay based on the
Bradford method from Bio-Rad (Hercules, CA, USA), using bovine
serum albumin as a standard. All other reagent grade chemicals were
supplied from standard commercial sources.
Postembedding immunogold cytochemistry
Immunogold electron microscopy quantiﬁcation was used to study
A1R and P2Y1R receptors in rat hippocampus, focusing on glutama-
tergic synapses. Animals were treated in accordance with the
guidelines of the Norwegian Committees on Animal Experimentation
(Norwegian Animal Welfare Act and European Communities Council
Directive of 24 November 1986-86/609/EEC). Receptor immunocy-
tochemistry was performed as described previously in Bergersen et al.
(2005), with some modiﬁcations. Wistar rats were deeply anesthetized
with an i.p. injection of pentobarbital. Brieﬂy, after transcardiac
perfusion with 0.1% glutaraldehyde and 4% formaldehyde in 0.1 m
sodium phosphate buffer (NaPi), pH 7.4, the brains from adult male
Wistar rats (300 g, n ¼ 3) were left in situ overnight (4  C). Then
hippocampal specimens were isolated, processed by cryoprotection in
different glycerol solutions, snap-frozen in liquid propane cooled by
liquid nitrogen and embedded in Lowicryl HM 20 through freeze-
substitution. Ultrathin sections (80 nm) were cut with a diamond knife
on a Reichert-Jung ultramicrotome and mounted on nickel grids
(300 mesh square, Electron Microscopy Sciences, USA). The sections
were processed at room temperature in solutions of 0.05 m Tris HCl
buffer, pH 7.4 containing 0.3% (w⁄v, for P2Y1R antibody) or 0.1%
(for A1R antibody) NaCl and 0.1% Triton X-100 (TBST) and
completed as stated below.
After ‘etching’ in sodium ethanolate to remove plastic from tissues,
sections were incubated in TBST containing 2% human serum
albumin (HSA) for 10 min and then overnight (around 20 h) with
speciﬁc primary antibodies diluted in TBST containing 2% HSA.
Antibodies against A1R (dilution 2 lg⁄mL) as well as the antibody
against the P2Y1R (dilution 4 lg⁄mL) were used. Sections were then
incubated with goat anti-rabbit immunoglobulins coupled to 10 -nm
gold particles, diluted 1 : 20 in TBST with 2% HSA and, for A1R
experiments, with 2 mg⁄mL polyethylene glycol to suppress the
formation of gold particle aggregates.
The ultrathin sections were processed both with single-labelled and
double-labelled procedures. In double-labelling experiments (Ottersen
et al., 1992), sections were treated with the antibody against P2Y1
(dilution as above) in the ﬁrst step (followed by 10-nm gold-labelled
secondary antibody) and then with the A1R antibody (dilution as
above) in the next step (revealed by 15-nm gold-labelled secondary
antibody). Exposure to formaldehyde vapours (80  C, 1 h) was used
between the two immunolabelling steps (Wang & Larsson, 1985) to
destroy the remaining free anti-IgG binding sites on the ﬁrst primary
and secondary antibodies. Potential cross-reactivity arising from the
subsequent use of another secondary antibody that would be directed
against the same species is prevented in this manner, allowing the
simultaneous detection of two different antigens when using two
primary antibodies from the same species, distinguishing the two by
means of different gold particle sizes (10 nm for P2Y1R, 15 nm for
A1R). The double-labelling approaches gave similar patterns as the
single-labelling protocol.
Negative control experiments also were performed, replacing the
incubation with the primary antibodies with 2% HSA in TBST;
staining was absent on sections that had been incubated in such a
solution. Ultrathin sections were contrasted in uranyl acetate and lead
citrate and observed in a Philips CM100 electron microscope.
Quantitative analysis
Electron micrographs were randomly taken in the hippocampus
(magniﬁcation 34 000·). Gold particles signalling both receptors
(P2Y1Ro rA 1R) were quantiﬁed as number of gold particles⁄lm
2 at
glutamatergic synapses (i.e. asymmetric synapses on dendritic spines)
in the stratum radiatum of area CA1 and CA3, as well as in the
juxtagranular part of the dentate molecular layer. The former are
formed by terminals of ipsilateral (Schaffer collaterals) and commis-
sural axon collaterals from CA3 pyramids), the latter by terminals of
mossy cells in the dentate hilus. Only synapses with clearly visible
postsynaptic membrane and postsynaptic density were selected for
analysis; essentially all synapses with this morphology are glutama-
tergic in these areas (for identiﬁcation criteria, see Gylterud Owe et al.,
2005). Quantitave analyses were carried out on sections single labelled
for either P2Y1Ro rA 1R. Speciﬁc membrane compartments were
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aptic vesicles membranes, the membrane overlying the postsynaptic
density (PSD), presynaptic membrane (opposite to the PSD), pre- and
post-perisynaptic membranes (corresponding to membrane lateral to
the presynaptic active zone and the PSD, extending laterally by half
the length of the PSD), extrasynaptic membranes (belonging to either
presynaptic terminals or postsynaptic spines⁄dendrites but excluding
the synaptic and perisynaptic membranes), postsynaptic intracellular
membranes, astroglia membranes and mitochondrial outer membranes
(Fig. 1; cf. Bergersen et al., 2005). In addition, gross distribution of
gold particles was recorded over the following location categories;
presynaptic terminal, postsynaptic spine, synaptic cleft, astrocytes,
mitochondria, extracellular and undeﬁned.
Particles located within 40 nm (perpendicular distance between the
centre of gold particle and the membrane) from different membranes
were recorded. This distance was chosen because 40 nm is approx-
imately equal to the lateral resolution of the immunogold method, i.e.
the maximum distance from the centre of the gold particle and the
epitope, determined experimentally (Chaudhry et al., 1995; Nagelhus
et al., 1998). The areas sampled were determined by grid point
analysis (Gundersen et al., 1988; Gundersen et al., 1998), and the
densities expressed as gold particles⁄lm
2. The distance between the
centres of gold particles, representing receptors, and the external face
of the postsynaptic density was determined along a perpendicular axis.
All gold particles located within the postsynaptic spine and the
presynaptic terminal were recorded; the width of the synaptic cleft was
also measured. The distribution of gold particles was compared with
that of grid points placed randomly over the sampled area (Gundersen,
V et al., 1998; Bergersen et al., 2003) in order to relate the
distributions of A1R and P2Y1R to a random distribution.
Rat brain membrane lysates and Western blotting
Western blot analysis on rat hippocampus and full-brain membranes
has been used to conﬁrm the speciﬁcity of the antibodies and the
presence of the receptors, as a further control.
The whole brain or the hippocampus were removed from Wistar rats
(200–300 g; n ¼ 3) and immediately processed, keeping on ice. The
tissues were suspended in 20 volumes of ice-cold 50 mm Tris HCl,
2m m MgCl2 buffer, pH 7.4, containing EDTA 1 mm and protease
inhibitors (benzamidine 0.16 mg⁄mL, trypsin inhibitor 0.03 mg⁄mL
and bacitracin 0.2 mg⁄mL) (buffer A). The tissues were then
homogenized with a Polytron homogenizer and after centrifugation
(48 000 · g for 10 min at 4  C), the membrane pellets were
resuspended and re-homogenized in buffer A containing ADA
2U⁄mL to obtain a concentration of 50 mg⁄mL (from original tissue
weight). After incubation for 30 min at 37  C, the samples were
centrifuged at 4  C and each pellet was resuspended to the used
concentration, boiled in Laemmli solution for 5 min, centrifuged at
room temperature for 5 min and the supernatant used for electropho-
resis (or kept at )20  C until use). Tissue membrane homogenates
(50 lg) were then processed by immunoblot following the method
Fig. 1. Schematic illustration of a synapse between a presynaptic terminal and a dendritic spine. Analysis of gold particle density (number of gold particles ⁄ lm
2)
was performed in speciﬁc membrane regions that were deﬁned as presynaptic vesicles membranes, the postsynaptic membrane overlying the postsynaptic density
(PSD; red), presynaptic membrane ‘active zone’ (i.e. opposite to the PSD; yellow), pre- and post-perisynaptic membranes on each side of the active zone (blue),
extrasynaptic membranes (belonging to either presynaptic terminals or postsynaptic spines ⁄ dendrites but excluding the synaptic and perisynaptic membranes; green),
postsynaptic intracellular membranes, astroglial plasma membranes (black) and mitochondrial outer membranes (brown). Note that the length of perisynaptic
membrane considered corresponds to half the total length of the PSD, on each side (the same is valid for the presynaptic perisynaptic membrane). Figure modiﬁed
from Bergersen et al. (2005).
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tions. Brieﬂy, samples were resolved by SDS-PAGE (10%), trans-
ferred to nitrocellulose membranes and incubated with primary
antibodies against A1R( 2lg⁄mL) (Lasley et al., 2000; Ponzio &
Hatton, 2005) or P2Y1R( 4lg⁄mL) (Wang et al., 2002; Franke et al.,
2004; Franke et al., 2006a) overnight at 4  C. Blots were developed
using the Millipore Immobilon TM Western Chemiluminescent HRP
Substrate Reagents (Millipore, MA, USA).
[
35S]GTPcS binding assay
For the preparation of rat HC, hippocampus from Wistar rats (200–
300 g; n ¼ 3) were processed essentially as described by Giuntini
et al. (2004) and the protein concentration of the samples was
determined.
A1R coupling to G proteins was evaluated assessing the ability of
the selective A1R-agonist CHA to stimulate [
35S]GTPcS binding in
membranes pre-treated for 10 min with buffer alone (control HC) or
100 nm MeSADP (MeSADP-treated HC). In parallel, aliquots of
control membranes were pre-incubated with the A1R selective
antagonist DPCPX (50 nm) for 10 min before the CHA-stimulation.
In the same way, P2Y1R⁄G protein coupling was evaluated
assessing the ability of the agonist MeSADP to stimulate [
35S]GTPcS
binding in membranes pre-treated for 10 min with buffer alone
(control HC) or 100 nm CHA (CHA-treated HC). In parallel, control
membranes were also treated with the P2Y1R selective antagonist
MRS2179 (10 lm), for 10 min before MeSADP-stimulation
(MRS2179-treated HC).
Aliquots of membrane homogenate (10 lg) were incubated in
0.1 mL of 25 mm Hepes NaOH, pH 7.4, 5 mm MgCl2,1 m m
EDTA, 100 mm NaCl (buffer A) containing ADA (0.2 U⁄mL),
10 lm GDP and 0.3 nm [
35S]GTPcS in the presence (stimulated)
and absence (basal) of a range of concentrations of CHA or
MeSADP (0.1 nm)10 lm). ADA was added to the assay to
eliminate the interference of endogenous adenosine in the basal
[
35S]GTPcS binding. Incubation was carried out at 25  C for 2 h.
Unspeciﬁc binding was deﬁned in the presence of 100 lm GTPcS;
resulted in less than 10% of total binding. Binding reactions were
terminated by rapid ﬁltration under vacuum through Whatman
GF⁄C glass ﬁbre ﬁlters (Millipore Corporation). The ﬁlters were
washed three times with 3 mL of 50 mm Tris HCl, 5 mm MgCl2,
pH 7.4 and then counted in a scintillation cocktail. The concentra-
tion-dependent increase in speciﬁc [
35S]GTPcS bindings by agonists
was expressed as the per cent increase above the basal unstimulated
binding (ﬁxed as 100%). All experiments were performed in
duplicate.
Data analysis
Data from immunogold cytochemistry localization were statistically
analysed with one-way anova and⁄or with Student’s t-test (two tails,
unpaired) by the computer program package GraphPad PRISM
Version 4.00 (GraphPad Software, San Diego, CA, USA) and reported
as mean ± SEM; statistical signiﬁcance refers to results where
P < 0.05 was obtained.
Agonist dose–response curves were analysed by the non-linear
regression curve-ﬁtting computer program GraphPad PRISM Ver-
sion 4.00 and the EC50 values were derived. Data are reported as
mean ± SEM of four different experiments (performed in duplicate).
Statistical analysis (Student’s t-test, two tails, unpaired) was performed
using GraphPad PRISM; signiﬁcance refers to P < 0.05.
Results
Immunolocalization
Postembedding immunogold electron microscopy was used to study
A1R and P2Y1R (Fig. 2A and B) in rat hippocampus, focusing on
glutamatergic synapses (i.e. small terminals with asymmetric synapses
on dendritic spines) and surroundings glia. For quantitative analysis
single-labelled sections, were randomly selected from CA1 and CA3
stratum radiatum, and juxtagranular part of the dentate molecular
layer, regions that are particularly high in nerve terminal glutamate
and glutamatergic markers (e.g. Cotman et al., 1987). As no overt
differences were noticed between the areas, they were analysed
together. Both A1R and P2Y1R were detected on synaptic and glial
membranes (Fig. 2A and B). Omitting the primary antibodies
abolished labelling (Fig. 2C), indicating a low unspeciﬁc signal due
to the detection system.
A1R and P2Y1R antibody speciﬁcity was addressed further by
Western blot analysis, using rat whole brain and hippocampus
membrane fractions (Fig. 2D and E). Results conﬁrmed the presence
of the two receptors and their antibody speciﬁcity. The A1R
immunoreactive band corresponds to the dimer form of A1Rs
(79 kDa; Fig. 2D) (Ciruela et al., 1995; Blum et al., 2002), while
the P2Y1R multiline pattern shows immunoreactive bands at 76, 40
and 35 kDa, corresponding to dimeric and monomeric variants
(Fig. 2E), in agreement with the literature data (Hoffmann et al.,
1999; Waldo & Harden, 2004).
The receptor distribution and localization was quantiﬁed in
different subcellular structures (Fig. 3A and B). The localization
of both receptors was expressed as the area density, the number of
gold particles⁄lm
2, in different structures in the vicinity of
hippocampal glutamatergic synapses, determining the area by point
analysis (Gundersen et al., 1988). Assuming the mitochondria do
not contain the receptors, the density of gold particles over
mitochondria may be taken to represent unspeciﬁc background
binding of antibodies. (This may be an overestimate of background
labelling, as the protein concentration in mitochondria is excep-
tionally high.) Both A1R and P2Y1R were highly concentrated in
the synaptic cleft area and in adjacent astrocytes, which were the
only compartments signiﬁcantly higher than mitochondria (Fig. 3A
and B). Because the spatial resolution of our immunolabelling
method is of the same order of magnitude as the distance between
different compartments⁄membranes in the tissue, an individual gold-
particle cannot be directly ascribed to any single structure.
Therefore, the association of gold particles with membranes was
analysed in several different ways.
First, we investigated the distribution of gold particles associated
with each kind of cellular membrane, in the vicinity of hippocampal
synapses, recording only particles within a distance equal to 10 nm
from each kind of membrane to minimize ‘cross ﬁring’ effects from
immunoreactivity in nearby structures. Immunogold single-labelling
of hippocampal sections showed that A1R (Fig. 4A) as well as P2Y1R
(Fig. 4B) are mainly associated with presynaptic membranes,
postsynaptic membranes overlying the PSDs, and astroglial mem-
branes. The high A1R presence on presynaptic-perisynaptic mem-
branes (P < 0.05, one-way anova, value vs. mitochondria) could be
inﬂuenced from receptors that are located in the active zone or as
‘reserve’ (Rebola et al., 2003); anyway the values on perisynaptic and
extrasynaptic membranes, both pre- and post-, can be inﬂuenced from
receptors that are instead on astroglia membranes, for the tight contact
between these and neurons. No other columns differed from the
background level, as indicated by the density of gold particles over
mitochondrial outer membranes (P > 0.05, one-way anova). Further,
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PSD were signiﬁcantly different compared to all other locations,
conﬁrming that A1Rs are associated with these membranes.
We then compared the distribution of gold particles representing
A1R and P2Y1R with the distribution of points spread randomly over
the pictures (Fig. 5). The gold particles ⁄random points ratio was
determined at different distances, from different membrane domains,
sorted into bins (10-20-30-40 nm). For the shortest distance (10 nm)
bins, the highest ratio values (approximately 2) were obtained, for
both A1R and P2Y1R, at presynaptic active zone membranes,
postsynaptic membranes overlying the PSD and astroglial membranes
(Fig. 5A and B), i.e. the same membrane domains that show the
highest labelling according to the analysis of Fig. 4. Also several other
neuronal membranes, but not mitochondrial outer membranes, had
ratios higher than one, consistent with a moderate enrichment of
receptors in them. As previously noted, the densities in perisynaptic
and extrasynaptic membranes could be inﬂuenced from gold particles
in active zone or in astroglial membranes.
Fig. 2. Localization of purinergic receptors in glutamatergic synapses in rat hippocampus by immunogold labelling. Electron micrographs of sections single
labelled for A1R (A) and for P2Y1R (B) are illustrated by examples from CA1 stratum radiatum (A main picture, B inset), CA3 stratum radiatum (A inset) and area
dentata (B main picture). Note that both A1R and P2Y1R were detected on synaptic and glial membranes; both over the postsynaptic density (black arrows) and over
the presynaptic (active zone) membranes at glutamatergic synapses and in glia (*). (C) Omission of primary antibody prevented all gold labelling (picture from CA3
stratum radiatum). Scale bar, 100 nm. m, mitochondria; S, postsynaptic dendritic spine; t, presynaptic axon terminal; *, astroglia. (D and E) Western blot analysis of
A1R (D) and P2Y1R (E), in rat whole brain and hippocampus membrane homogenates. Rat tissue membranes were lysed, proteins were separated by 10%
polyacrylamide SDS-PAGE and probed with the anti-A1R and anti-P2Y1R antibodies used for immunocytochemistry.
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(B) in different intra- and extracellular compartments. Note that both receptors
are enriched at synapses and astroglia, compared to all other compartments.
Data, from single labelling experiments, report the localization of receptors as
the density (gold particles ⁄ lm
2; mean ± SEM) in the different compartments
in the vicinity of hippocampal glutamatergic synapses (i.e. asymmetric
synapses on spines, see Materials and methods; randomly selected, from
n ¼ 3 animals; ﬁve grids analysed for A1R and six grids for P2Y1R); the areas
of the compartments were measured by point analysis (see Materials and
methods). The numbers of gold particles on each structure are, in order 323,
230, 1, 52, 24, 31, 15 for A1R; 330, 311, 5, 112, 35, 31, 32 for P2Y1R. Areas
analysed for each compartment are, in order 10.8, 7.7, 0.1, 1.1, 0.2, 0.6, 1.3,
1.0 lm
2 for A1R, 12.1, 8.8, 0.2, 2.1, 0.2, 0.9, 1.7, 0.8 lm
2 for P2Y1R.
(A) A1R. **P < 0.01, one-way anova, all compartments compared to
mitochondria (Dunnett’s multiple comparison test). Synaptic cleft is signiﬁ-
cantly different compared to all other domains (
#P < 0.01, one-way anova,
Tukey’s multiple comparison test). Astrocytes and synaptic cleft columns
showed higher receptor density (
§P < 0.05, Student’s t-test, two-tails, unpaired)
compared to mitochondria. (B) P2Y1R; *P < 0.05, **P < 0.01 all domains
compared to mitochondria, one-way anova (Dunnett’s multiple comparison
test). Synaptic cleft is signiﬁcantly different compared to all other domains
(
#P < 0.001 vs. all except astrocytes, P < 0.01 vs. astrocytes, One-way anova,
Tukey’s multiple comparison test).
Fig. 4. Distribution of immunogold particles indicating A1R (A) or P2Y1R (B)
over different categories of cellular membranes in the vicinity of hippocampal
synapses. Both receptor types are enriched over presynaptic as well as
postsynaptic membranes and over astroglial membranes. Only particles located
within a distance equal to 10 nm from each kind of membrane were recorded, to
minimize ‘cross ﬁring’ effects from immunoreactivity in nearby structures. The
data are presented in the same way, and are from the environments of the same
synapses, as are the data in Fig. 3. The sizes of the areas sampled for gold
particles (± 10 nm on each side of the membrane) were determined by point
analysis.Areasanalysedforeachcategoryare,inorder3.8,0.5,0.3,1.4,0.7,0.3,
1.1, 0.3, 0.6, 0.6 lm
2 for A1R; 5.1, 0.8, 0.3, 1.6, 0.8, 0.4, 2.0, 0.6, 1.2, 0.7 lm
2
for P2Y1R. The numbers of gold particles within 10 nm from each membrane
column are, in order 196, 126, 22, 98, 141, 19, 54, 32, 57, 12 for A1R.; 260, 81,
15, 101, 124, 26, 74, 36, 116, 27 for P2Y1R. The density of gold particles over
the outer membrane of mitochondria gives an estimate of the background level.
(A) *P < 0.05, **P < 0.01, all columns compared to mitochondria back-
ground level, one-wayanova (Dunnett’s multiplecomparison test). Presynaptic
membrane and PSD are signiﬁcantly different compared to all other membrane
categories (
#P < 0.01, one-way anova, Tukey’s multiple comparison test).
(B) **P < 0.01, all columns compared to mitochondria background level, one-
way anova (Dunnett’s multiple comparison test). PSD is signiﬁcantly different
compared to all other columns except for presynaptic membranes and astroglial
membranes (
#P < 0.01, one-way anova, Tukey’s multiple comparison test).
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then measured and compared with a random distribution (Fig. 6). Note
that for both A1R (Fig. 6A) and P2Y1R (Fig. 6B) the mean distance of
gold particles is shorter than that of random points in all membranes,
except in mitochondrial outer membranes (which represent an estimate
of background labelling).
To dissect further the synaptic localization of A1R and P2Y1R, all
the hippocampal glutamatergic synapses previously analysed were
processed to record the percentage distribution of both receptors as a
function of the perpendicular distance from the postsynaptic mem-
brane overlying the PSD (Fig. 7). The percentage distribution of A1Rs
in the synaptic area (Fig. 7A, left) showed that A1R are located over
both the PSD and the presynaptic membrane, although the density is
highest over the latter. The inﬂuence of the extracellular location of the
epitope recognized by the A1R antibody may have contributed to the
high level of gold particles located in the synaptic cleft. A1R-gold
particles situated over the synaptic cleft were preferentially associated
with the presynaptic membrane (Fig. 7A, right), indicating a shared
distribution of the receptor between the presynaptic and postsynaptic
sides. P2Y1Rs were relatively more distributed towards the PSD
membrane (Fig. 7B, left), compared to A1Rs, and gold particles in the
cleft showed less enrichment on the presynaptic side (Fig. 7B, right).
These results are consistent with a high degree of co-localization of the
two types of receptor, but with relatively less of P2Y1R than of A1R
on the presynaptic side.
In conclusion, A1R and P2Y1R are co-localized in synaptic and
astroglial membranes in glutamatergic synapses and surrounding glial
membranes in the hippocampus. The quantitative analyses of single-
labelling data were conﬁrmed by the qualitative analysis of double-
labelling experiments (Fig. 8). The double-labelling approach gave
similar patterns as the single labelling protocol; the receptors were
detected together in the same structures and both were associated with
synaptic and astroglial membranes (Fig. 8).
Functional assays
The effect of P2Y1R activation on A1R⁄G protein coupling was
measured in HC by evaluating the ability of the A1R agonist CHA to
stimulate G protein activation following 100 nm MeSADP pre-
incubation (for 10 min). In control HC, CHA stimulated G protein
activation with an EC50 of 30.60 ± 3.99 nm (Fig. 9). To test the CHA-
mediated selective A1R activation in our model, we also stimulated
Fig. 5. Histogram of gold particles ⁄ random points ratio; gold particles were grouped in bins depending the distance (10, 20, 30, 40 nm) from each kind of
membrane, at hippocampal glutamatergic synapses and surrounding glia. The percentage of the total number of gold particles that occurred in each bin was divided
by the percentage of the total random points (within 40-nm distance) that occurred in the same bin; the ratio gives the distribution of receptors relative to a random
distribution. A ratio >1 for the shorter distance bins (10 nm and 20 nm), indicates a close association with the membrane observed. Note the higher ratios (arrows)
for short distances at presynaptic active zone membranes, postsynaptic membranes overlying the PSD and astroglial membranes, for both A1R (A) and P2Y1R (B).
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pre-incubated for 10 min). DPCPX prevented CHA-mediated G pro-
tein coupling in HC (Fig. 9), showing that the G protein activation is
selectively driven by A1R. The CHA-mediated effect was abolished in
the presence of the selective A1R antagonist DPCPX (50 nm),
conﬁrming A1R speciﬁc activation.
Membrane pre-incubation with 100 nm MeSADP induced
a right-shift of the CHA dose⁄response curve (EC50 ¼ 106.26 ±
16.39 nm), suggesting a signiﬁcant impairment in A1R-G protein
coupling when P2Y1 receptor is activated (t-test, two-tails, unpaired
P ¼ 0.004 for EC50 of MeSADP-treated HC vs. control HC;
Fig. 9).
On the other hand, the A1R activation effect on P2Y1R⁄G protein
coupling was measured by evaluating the ability of the P2Y1R agonist
MeSADP to stimulate G protein activation in the absence or the
presence of 100 nm CHA (pre-incubated for 10 min). In control HC,
Fig. 6. Average distances of immunogold particles from membranes. The
values are the mean ± SEM of the distances of gold particles (white bars) or
random points (black bars) located within a distance equal to 40 nm from
different membrane categories, in the vicinity of glutamatergic synapses in rat
hippocampus. Note that for both A1R (A) and P2Y1R (B) the mean distance
of gold particles is shorter than that of random points in all membranes, except
in mitochondria outer membranes (which represent background labelling). The
total number of particles counted is for A1R gold particles 286, 241, 34, 159,
230, 38, 101, 37, 91, 241; for P2Y1R gold particles 392, 238, 41, 183, 247, 47,
145, 44, 207, 44; for A1 random points 457, 212, 46, 313, 218, 48, 187, 39,
149, 177; for P2Y1 random points 457, 127, 47, 270, 132, 55, 269, 60, 162, 63.
Fig. 7. Distribution of immunogold particles across the synaptic cleft. The
histograms on the left show the percentage of gold particles representing A1R
(A) and P2Y1R (B) in the synaptic area, as a function of the distance up to
100 nm from the postsynaptic membrane at the PSD. The distance between the
centre of gold particles and the external face of the PSD was determined along a
perpendicular axis (cf. Fig. 1). Positive columns (10 to 100 nm) represent the
postsynaptic spine; negative columns ()20 to )100 nm) the presynaptic
terminal; the )10 nm column represents the synaptic cleft (i.e. position 0 to
)10 nm). The actual width of the synaptic cleft was 11.5 ± 0.4 nm
(average ± SEM, n ¼ 79). Numbers of gold particles considered in the
analysis are n ¼ 266 for A1R; n ¼ 296 for P2Y1R. All synapses previously
analysed have been processed in this analysis. Note that the highest particle
counts for A1R as well as P2Y1R were in the PSD bin. The histograms on the
right show the distribution of immunogold particles within the synaptic cleft.
The percentage of the total number of gold particles located in the synaptic cleft
(n ¼ 41 for A1R; n ¼ 28 for P2Y1R), in function of the distance from the outer
face of the PSD; presynaptic side, position between 0 and )3 nm; postsynaptic
side, between )6 and )10 nm; middle of cleft, between )3 and )6 nm. The
distributions within the synaptic cleft indicate that both A1R (A) and P2Y1R
(B) are located presynaptically as well as postsynaptically.
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35S]GTPcS binding with an EC50 of
0.851 ± 0.147 nm (Fig. 10).
To test the selectivity of MeSADP for P2Y1 receptor subtype in our
model, we also stimulated HC in the presence of the selective P2Y1R
antagonist 10 lm MRS2179 (pre-incubated for 10 min). MRS2179
blocked MeSADP-mediated G protein coupling in HC (Fig. 10),
showing this G protein activation is selectively driven by P2Y1R, and
other P2Y receptors sensitive to MeSADP (P2Y12)13) have no
signiﬁcant signal component in rat hippocampus. Membrane CHA
pre-incubation induced a signiﬁcant increase in MeSADP potency to
activate P2Y1R-G protein coupling, with an EC50 of
0.393 ± 0.058 nm (t-test; two-tails, unpaired P ¼ 0.03 vs. control
HC), without signiﬁcantly affecting the G protein coupling efﬁcacy
level of the agonist dose⁄response curve (Fig. 10).
CelltreatmentwithMeSADPorCHAinducedanincreaseinthebasal
[
35S]GTPcS binding value, thus suggesting the agonists affect the
G protein activation state. Values are reported as fmol⁄mg of proteins;
control HC ¼ 183.96 ± 30.2; MeSADP HC ¼ 298.65 ± 30.18; CHA
Fig. 8. Qualitative co-localization of P2Y1R and A1R in glutamatergic synapses (randomly selected) and surrounding glia, in rat hippocampus CA3 stratum
radiatum. Electron micrograph of a section double labelled for A1R (large gold particles, 15 nm) and P2Y1R (small gold particles, 10 nm). The double-labelling
approach gave similar patterns as the single-labelling protocol. Note that the receptors were detected together in the same structures. A1R and P2Y1R appeared co-
localized (qualitative data) on the PSD (black arrows) and on astroglia (*). Scale bar, 100 nm. M, mitochondria; S, postsynaptic spine; t, presynaptic terminal; *,
astroglia.
Fig. 9. Effect of P2Y1R activation on A1R agonist-mediated G protein
coupling. Dose–response curves of CHA-stimulated [
35S]GTPcS binding were
obtained incubating control HC (n) and MeSADP-treated (100 nm)H C( d)
with different agonist concentration (0.1 nm)10 lm). Data are expressed as
percentage of [
35S]GTPcS speciﬁc binding over basal value, set to 100%, and
are reported as mean ± SEM (n ¼ 4), all performed in duplicate. Student’s
t-test, two-tails, unpaired: P ¼ 0.004 for EC50 of Control HC vs. MeSADP-
treated HC. Aliquots of HC were also pre-exposed to the selective A1R
antagonist DPCPX (50 nm; m) and then stimulated by CHA (0.1 nm)10 lm).
Fig. 10. Effect of A1R activation on P2Y1R agonist-mediated G protein
coupling. Dose–response curves of MeSADP-stimulated [
35S]GTPcS binding
were obtained incubating control HC (n) and CHA-treated (100 nm)H C( d)
with different agonist concentration (0.1 nm)10 lm). Data are expressed as
percentage of [
35S]GTPcS speciﬁc binding over basal value set to 100% and
are reported as mean ± SEM (n ¼ 4), all performed in duplicate. Student’s
t-test, two-tails, unpaired: P ¼ 0.03 for EC50 of control HC vs. CHA-treated
HC. Aliquots of HC were also pre-exposed to the selective P2Y1R antagonist
MRS2179 (10 lm; MRS2179-treated HC; m) and then stimulated by MeSADP
(0.1 nm)10 lm). Data are expressed as percentage of [
35S]GTPcS speciﬁc
binding over basal value set to 100% and are reported as mean ± SEM (n ¼ 4),
all performed in duplicate.
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This is the ﬁrst study on A1R and P2Y1R localization and
co-localization in hippocampus by postembedding immunogold
electron microscopy analysis. This high resolution technique is able
to show the precise subcellular localization of receptors in different
subcellular compartments and cell populations (e.g. Bergersen et al.,
2003). The purinergic receptors proved to be mainly associated with
membrane domains. Single-labelling immunolocalization data showed
a signiﬁcant enrichment of both A1R and P2Y1R mainly in
postsynaptic membranes at the PSD, in presynaptic active zones,
and in astroglial membranes at glutamatergic synapses and surround-
ing glia in the rat hippocampus. The same conclusion was arrived at
by analysing the data in different ways, in order to partly overcome the
limits posed by ‘cross ﬁring’ effects antigen located in closely spaced
neighbouring membranes. Because of these, the exact labelling
densities of the individual membranes cannot be determined. While
the three membrane categories mentioned contain higher levels of both
of the purinergic receptors studied, low or moderate labelling may
exist in other membrane categories. The data suggest that there may be
relatively higher densities of A1R than of P2Y1R at the presynaptic
compared to the postsynaptic membrane. Part of this observed
difference might be attributable to the fact that the antibodies were to
extracellular and intracellular epitopes, respectively, although the inner
and outer surfaces of the plasma membrane are only 4–5 nm apart, i.e.
an order of magnitude less than the lateral resolution of the
immunogold method. However, the main conclusion is that the two
receptor types are similarly distributed, compatible with a high degree
of co-localization. This was born out by double-labelling experiments
that showed A1R and P2Y1R to be closely spaced along synaptic and
glial membranes.
In parallel, the speciﬁcities of A1R and P2Y1R antibodies used in
immunohistochemistry, were assessed by immunoblotting assay using
rat whole brain and hippocampus membrane fractions. The obtained
results were according to literature data (Hoffmann et al., 1999; Blum
et al., 2002; Moore et al., 2002; Waldo & Harden, 2004) and
conﬁrmed that antibodies selectively recognized A1 and P2Y1
receptors in hippocampal membranes.
Our high resolution data serve to extend and reconcile previous
reports obtained with lower resolution methods. Thus A1R immuno-
reactivity has been reported in hippocampus both at presynaptic and
postsynaptic terminals but not at glial cells (Ochiishi et al., 1999); an
immunohistochemical study in the rat hippocampus has concluded
that A1Rs were mostly located in axons rather than in nerve
terminals (Swanson et al., 1995), whereas work on synaptosomal
fractions (Rebola et al., 2003) has suggested that A1Rs are enriched in
nerve terminals and are mainly located in synapses, both in the
presynaptic active zone and in the PSD membranes. P2Y1R immu-
noreactivity has been found in astroglia and in different kinds of
neurons in hippocampus (Moran-Jimenez & Matute, 2000), especially
in ischemic sensitive areas while at the same time another study
reported a striking neuronal localization for P2Y1R (human brain,
Moore et al., 2000). P2Y1Rs have been reported to be present and
active on astrocytes all around the brain (Franke et al., 2001; Volonte
et al., 2006). A high degree of co-localization of A1R and P2Y1R has
been found in rat hippocampus by immunoﬂuorescence experiments
but without cellular and subcellular identiﬁcation (Yoshioka et al.,
2002).
We studied A1Rs and P2Y1Rs in the hippocampal region consid-
ering the fact that the hippocampus has been identiﬁed as a major
target site for numerous disease processes (Bachevalier & Meunier,
1996; Harry & Lefebvre d’Hellencourt, 2003), and considering the
generally assumed involvement of purinergic receptors in patho-
physiological mechanisms and in the modulation of brain damage
(Fredholm, 1997; Franke et al., 2006b). Ischemia, to which hippo-
campus is particularly vulnerable, produces a marked increase in
glutamate within the brain extracellular space (Benvensiste et al.,
1984; Hagberg et al., 1985), thereby triggering excitotoxic injuries
(Choi & Rothman, 1990). Because of the importance of glutamate in
pathological conditions and because its release, in neurons and in
astrocytes, is modulated both through A1R (Rudolphi et al., 1992;
Masino et al., 2002) and P2Y1R (Rodrigues et al., 2005; Franke et al.,
2006a; Jourdain et al., 2007), the present study was focused on A1R–
P2Y1R localization and co-localization within and in the vicinity of
glutamatergic synapses.
Our results provide direct morphological support for the previous
suggestions that both of these receptors contribute to and interact in
the modulation of glutamate release (Rudolphi et al., 1992; Mendoza-
Fernandez et al., 2000; Masino et al., 2002; Kawamura et al., 2004;
Rodrigues et al., 2005).
Functional interaction
The functional interaction of A1Rs and P2Y1Rs suggested by the
morphological observations was subsequently conﬁrmed through
measurement of G protein activation initiated by the A1R agonist,
CHA, or the P2Y1R agonist, MeSADP, respectively, and modiﬁcation
of the response through pre-incubation with the other agonist. Because
the receptors on study are coupled to different G protein subtypes
(Munshi et al., 1991; Yoshioka & Nakata, 2004) and to different
intracellular signalling pathways, the [
35S]GTPcS binding method was
chosen to investigate the A1R–P2Y1R interaction and their reciprocal
modulation at the membrane level, allowing any change in their
functioning to be determined independently of the second messenger
systems activated (Lorenzen et al., 1996).
According to literature data (Gao et al., 2003; Dixon et al., 2004;
Niebauer et al., 2005), the selected agonist pre-incubation times and
concentrations pre-stimulating A1R and P2Y1R (100 nm CHA and
100 nm MeSADP, respectively) allow a selective and maximal
receptor activation.
The EC50 for CHA in stimulating A1R-G protein coupling was
around 30 nm. Although CHA has been reported to block [
3H]DPCPX
binding at A1R with a Ki of approximately 5 nm in rat hippocampus
(Maemoto et al., 1997), according to our data, higher EC50 values for
different A1R agonists in the [
35S]GTPcS binding assay have been
found (Lorenzen et al., 1996; Cordeaux et al., 2004). In order to
obtain a selective stimulation of A1R, without interference of other
receptor subtypes, we have chosen treatment of hippocampal mem-
branes with 100 nm agonist CHA. In fact in hippocampus, although
A1Rs are the mainly expressed adenosine receptors, the presence of
low amounts of A2A and A3 receptors have been described (Duarte
et al., 2006; Lopes et al., 2003). Nevertheless, these receptors have a
different agonist pharmacological proﬁle; CHA, in fact, shows a high
afﬁnity towards A1Rs (Murphy & Snyder, 1982; Maemoto et al.,
1997) and a low afﬁnity towards A2A ones (Cunha et al., 1996; Gao
et al., 2003). Even if, in our experimental conditions, the EC50 for
CHA in stimulating A1R-G-protein coupling was around 30 nm, the
Hippocampal A1–P2Y1 purine receptor cross-talk 899
ª The Authors (2007). Journal Compilation ª Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 26, 890–902real binding potency of CHA to A1R sites is around a few nanomolar
units or indeed in the subnanomolar range in rat hippocampus, so the
agonist at 100 nm is able to selectively saturate A1R binding sites.
This was conﬁrmed by an antagonist dose–response curve, DPCPX
was able to completely abrogate the effects mediated by CHA from 1
to 100 nm. At higher agonist concentrations the antagonistic effect of
DPCPX was reduced suggesting that the agonist binds to a different
receptor population, probably identiﬁable with A2A receptor sites.
On the other hand, in our results, MeSADP showed subnanomolar
potency in stimulating P2Y1R. Because of the absolute potency of
nucleoside tri- and diphosphates for P2Y receptors is dependent on the
levels of receptor protein expression, typical EC50 values are not easily
deﬁned for speciﬁc agonists at particular P2Y receptor subtypes in
different tissue preparations and cell lines (Volonte ` et al., 2006). In
accordance with our results, low nanomolar and subnanomolar EC50
values have been reported for MeSADP towards human P2Y1R,
expressed in astrocytoma 1321 N1 cells (Palmer et al., 1998; Niebauer
et al., 2005), and rat P2Y1R, expressed in HEK 293 cells (Vohringer
et al., 2000).
MeSADP is the principal agonist not only at P2Y1R but also at
P2Y12)13 receptors, that are coupled to GI proteins and are expressed
(mRNA) in the brain (Hollopeter et al., 2001; Zhang et al., 2002;
Sasaki et al., 2003), even if not at high level in the hippocampus
(Fumagalli et al., 2004; Amadio et al., 2006). To conﬁrm that in our
model the MeSADP-mediated G-protein activation was mainly driven
by P2Y1R, we also stimulated hippocampal membranes in the
presence of the selective P2Y1R antagonist, MRS2179. MRS2179
was able to block the MeSADP-mediated response, conﬁrming the
P2Y1R involvement as no antagonistic effects have been demonstrated
on P2Y12)13 receptors at the MRS2179 concentrations used (Moro
et al., 1998; Von Kugelgen, 2006).
The results obtained on A1R–P2Y1R cross-talk in hippocampus
showed that, stimulating one receptor, the functioning of the other was
changed. In particular, P2Y1R pre-activation caused an impairment in
A1R–G protein coupling with a reduction in A1R agonist potency; on
the other hand, A1R pre-activation induced an increase in P2Y1R
functional coupling to G proteins. Our results are in agreement with
the previously reported reduction in the A1R ligand afﬁnities in cells
co-expressing both A1R and P2Y1R (Yoshioka et al., 2001). Various
studies have reported that ATP, massively released after brain damage,
acts to modulate not only its own P2Y1R but also A1R (Hourani et al.,
1991; Piper & Hollingsworth, 1996; Masino et al., 2002; Fredholm
et al., 2003; Yoshioka & Nakata, 2004).
The functional consequence of this A1–P2Y1 receptor cross-talk is
complicated by the availability time and the balance of their
endogenous ligands. Extracellular ATP, rapidly available due to direct
release into the extracellular space, and adenosine, available after ATP
breakdown, are tightly regulated by rapid metabolism and re-uptake
(Zimmermann, 2000) and can be differently regulated in physiological
or pathological conditions; in fact the ecto-nucleotidase chain has
proved to be up-regulated in ischemically damaged tissues (Braun
et al., 1998).
Data, at present, have shown the A1R–P2Y1R interaction mecha-
nism may be used to ﬁne-tuning the purinergic signalling, including
the inhibition of neurotransmission (Nakata et al., 2004). Considering
the new information available and the A1R and P2Y1R involvement in
glutamatergic transmission modulation (Mendoza-Fernandez et al.,
2000; Masino et al., 2002; Kawamura et al., 2004; Rodrigues et al.,
2005), we can speculate that there is an A1R–P2Y1R cross-talk in rat
hippocampal glutamatergic synapses and surroundings glia, where
these receptors are co-localized. This might therefore be one of the
mechanisms for the adenine nucleotide-mediated inhibition of gluta-
matergic neurotransmitter release. Therefore, as suggested for aden-
osine A1 and A2A receptors in striatal (Ciruela et al., 2006) and
hippocampal (Rebola et al., 2005) glutamatergic nerve terminals, a
cross-talk⁄heteromerization of A1R–P2Y1R could exert a ﬁne-tuning
modulation of glutamatergic neurotransmission, providing a switch
mechanism by which low and high concentrations of adenosine or
purines could regulate glutamate release.
Because of the high level of complexity of purinergic receptor
signalling (Volonte ` et al., 2006) and the regulation of glia–neuron and
glia–glia communications by extracellular purines (Franke et al.,
2006b; Jourdain et al., 2007), the present work opens the way to
further investigation of the A1R–P2Y1R system interaction on
astrocyte cell populations, which communicate bi-directionally with
neurons (Newman, 2003; Bezzi et al., 2004; Jourdain et al., 2007) and
contribute to damage or to regeneration after CNS injury (Franke
et al., 2001; Anderson et al., 2003).
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